Chemical genomic profiling to identify intracellular targets of a multiplex kinase inhibitor
The identification of the kinase or kinases targeted by protein kinase inhibitors is a critical challenge in validating their use as therapeutic agents or molecular probes. Here, to address this problem, we describe a chemical genomics strategy that uses a direct comparison between microarray transc...
Saved in:
Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 10; pp. 3587 - 3592 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
National Academy of Sciences
08-03-2005
National Acad Sciences |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The identification of the kinase or kinases targeted by protein kinase inhibitors is a critical challenge in validating their use as therapeutic agents or molecular probes. Here, to address this problem, we describe a chemical genomics strategy that uses a direct comparison between microarray transcriptional signatures elicited by an inhibitor of unknown specificity and those elicited by highly specific pharmacological inhibition of engineered candidate kinase targets. By using this approach, we have identified two cyclin-dependent kinases, Cdk1 and Pho85, as the targets of the inhibitor GW400426 in Saccharomyces cerevisiae. We demonstrate that simultaneous inhibition of Cdk1 and Pho85, and not inhibition of either kinase alone, by GW400426 controls the expression of specific transcripts involved in polarized cell growth, thus revealing a cellular process that is uniquely sensitive to the multiplex inhibition of these two kinases. Our results suggest that the cellular responses induced by multiplex protein kinase inhibitors may be an emergent property that cannot be understood fully by considering only the sum of individual inhibitor-kinase interactions. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 To whom correspondence should be addressed at: Department of Cellular and Molecular Pharmacology, University of California, 600 16th Street, Box 2280, Genentech Hall, Room N512D, San Francisco, CA 94143-2280. E-mail: shokat@cmp.ucsf.edu. This paper was submitted directly (Track II) to the PNAS office. Author contributions: C.K., L.F.K., H.D.M., and K.M.S. designed research; C.K., D.M.K., S.H.D., and R.W.H. performed research; C.K. and D.M.K. analyzed data; and C.K. wrote the paper. Edited by Susan S. Taylor, University of California at San Diego, La Jolla, CA Abbreviations: CDK, cyclin-dependent kinase; ESR, environmental stress–response. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0407170102 |